Revolutionizing Infectious Disease: Dr. Paul’s Journey Kumar Jeetendra | May 12, 2025 In this captivating episode of our podcast series, we feature the world-renowned microbiologist, inventor, and thought leader in anti-infectives and infectious disease R&D, Dr. Maneesh Paul. Key Highlights: The story of Enmetazobactam – India’s first indigenously developed anti-infective and its journey from concept to global approvals (DCGI, USFDA, UKMHRA, EMA). Aspects of AMR, Planetary Health, …
Alembic Pharma Gets USFDA Nod for Ticagrelor 60 mg Tablets Kumar Jeetendra | November 1, 2025 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 60 mg. The approved ANDA is therapeutically equivalent to the reference listed drug (RLD), Brilinta Tablets, 60 mg, of AstraZeneca Pharmaceuticals LP (AstraZeneca). Ticagrelor tablets are …
